GREAT LAKES ADVISORS, LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1078013 CHICAGO, IL

Position in LNTH

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$3,008,210

+$843,006 QoQ

Shares Held

39,660

+21.9% QoQ

Ownership

0.061%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GREAT LAKES ADVISORS, LLC holds $39,063,263 across 13 Drug Manufacturers - Specialty & Generic names. LNTH ranks #5 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	14,418	$8,549,585
2	ELAN	Elanco Animal Health Inc	347,911	$8,325,509
3	ANIP	Ani Pharmaceuticals Inc	67,130	$5,162,296
4	PBH	Prestige Consumer Healthcare Inc.	69,573	$4,123,590
5	LNTH	Lantheus Holdings, Inc. This page	39,660	$3,008,210
6	SUPN	Supernus Pharmaceuticals, Inc.	48,180	$2,490,424
7	VTRS	Viatris Inc	158,513	$2,141,509
8	ZTS	Zoetis Inc.	16,241	$1,919,848

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,008,210	39,660	+21.9%	Shares	Sole	2026-05-12
2025-12-31	$2,165,204	32,535	0.0%	Shares	Other	2026-02-12
2025-09-30	$1,668,719	32,535	-23.4%	Shares	Other	2025-11-03
2025-06-30	$3,476,511	42,469	+17.4%	Shares	Sole	2025-08-11
2025-03-31	$3,529,996	36,168	-18.3%	Shares	Sole	2025-05-16
2024-12-31	$3,958,157	44,245	-11.4%	Shares	Sole	2025-02-10
2024-09-30	$5,482,999	49,959	-9.8%	Shares	Sole	2024-11-04
2024-06-30	$4,445,817	55,372	-7.2%	Shares	Sole	2024-08-06
2024-03-31	$3,713,362	59,662	+2.4%	Shares	Sole	2024-05-08
2023-12-31	$3,611,996	58,258	-36.2%	Shares	Sole	2024-02-08
2023-09-30	$6,340,883	91,262	-10.1%	Shares	Sole	2023-11-07
2023-06-30	$8,517,880	101,500	-37.7%	Shares	Sole	2023-08-10
2023-03-31	$13,448,280	162,891	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.